IL-17A exacerbates synovial inflammation in osteoarthritis via activation of endoplasmic reticulum stress
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2024.113733 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Wen Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, 242, Guangji Road…. Hauptthemen laut MEDLINE: Endoplasmic Reticulum Stress, Interleukin-17, Osteoarthritis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
The primary clinical manifestations of osteoarthritis (OA) are joint pain and restricted movement capabilities. Synovial inflammation, serving as an initiator of OA progression, intensifies cartilage damage via the generation of various deleterious agents, including pro-inflammatory cytokines and nociceptive mediators. Despite extensive research on modulating synovial inflammation to retard OA progression, the underlying pathophysiological mechanisms of synovial inflammation in OA remain elusive. Interleukin-17A (IL-17A), a pro-inflammatory cytokine released by activated T lymphocytes, is a therapeutic target for numerous inflammatory and autoimmune pathologies. This study investigates the role and mechanism of IL-17A in OA synovial inflammation using both in vivo and in vitro models and examines the impact of the endoplasmic reticulum stress (ERS) inhibitor, 4-Phenylbutyric Acid (4-PBA). Our findings indicate that IL-17A may be implicated in synovial inflammation through ERS and suggest a potential therapeutic direction for mitigating synovial inflammation in OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, 242, Guangji Road, Suzhou, Jiangsu, China.
- Department of Anesthesiology, the First People's Hospital of Yancheng, 66, Renmin South Road, Yancheng, Jiangsu, China.
- Department of Orthopedics, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou, Jiangsu, China.
- Orthopedics and Sports Medicine Center, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, 242, Guangji Road, Suzhou, Jiangsu, China.
- Orthopedics and Sports Medicine Center, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, 242, Guangji Road, Suzhou, Jiangsu, China. Electronic address: 13913109339@16…
- Department of Orthopedics, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou, Jiangsu, China. Electronic address: cgdong@suda.edu.cn.
Zitieren
APA
Sun, W., Li, X., Zhang, L., Zhang, Y., Shi, Y., Tao, H., Zhou, J., Hao, Y., Chen, G., Gu, C., & Yang, X. (2025). IL-17A exacerbates synovial inflammation in osteoarthritis via activation of endoplasmic reticulum stress. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113733
Vancouver
Sun W, Li X, Zhang L, Zhang Y, Shi Y, Tao H, et al. IL-17A exacerbates synovial inflammation in osteoarthritis via activation of endoplasmic reticulum stress. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2024.113733
BibTeX
@article{Sun2025,
author = {Sun, Wen and Li, Xueyan and Zhang, Liyuan and Zhang, Yuheng and Shi, Yi and Tao, Huaqiang and Zhou, Jing and Hao, Yuefeng and Chen, Guangdong and Gu, Chengyong and Yang, Xing},
title = {IL-17A exacerbates synovial inflammation in osteoarthritis via activation of endoplasmic reticulum stress},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2024.113733}
}
EUVIMED